drugset / Trial / NCT02233647

Phendimetrazine and Cocaine

NCT02233647

Non-randomizedCrossoverTriple-blindBasic science

Summary

This study will determine the safety and tolerability of phendimetrazine (Bontril®) as a pharmacotherapy for cocaine use disorder. A rigorous, inpatient human laboratory study will be conducted in which the subjective and physiological effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.

Timeline

Start
2014-09
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cocaine Small molecule